Your browser doesn't support javascript.
loading
In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.
Mamidi, Rao N V S; Dallas, Shannon; Sensenhauser, Carlo; Lim, Heng Keang; Scheers, Ellen; Verboven, Peter; Cuyckens, Filip; Leclercq, Laurent; Evans, David C; Kelley, Michael F; Johnson, Mark D; Snoeys, Jan.
Afiliação
  • Mamidi RNVS; Preclinical Development & Safety, Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Dallas S; Preclinical Development & Safety, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Sensenhauser C; Preclinical Development & Safety, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Lim HK; Preclinical Development & Safety, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Scheers E; Preclinical Development & Safety, Janssen Research & Development, Beerse, Belgium.
  • Verboven P; Preclinical Development & Safety, Janssen Research & Development, Beerse, Belgium.
  • Cuyckens F; Preclinical Development & Safety, Janssen Research & Development, Beerse, Belgium.
  • Leclercq L; Preclinical Development & Safety, Janssen Research & Development, Beerse, Belgium.
  • Evans DC; Preclinical Development & Safety, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Kelley MF; Preclinical Development & Safety, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Johnson MD; Preclinical Development & Safety, Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Snoeys J; Preclinical Development & Safety, Janssen Research & Development, Beerse, Belgium.
Br J Clin Pharmacol ; 83(5): 1082-1096, 2017 05.
Article em En | MEDLINE | ID: mdl-27862160

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canagliflozina / Hipoglicemiantes / Modelos Biológicos Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canagliflozina / Hipoglicemiantes / Modelos Biológicos Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos